hdr isap 2019

Post-Doc Position available

Postdoc positions available:

The Clinical Pharmacy & Biochemistry group at Freie Universität Berlin is recruiting a postdoctoral researcher with a focus on antimicrobial resistance. The GlobalResist project aims to forecast the evolution of antimicrobial resistance and thus take a new approach to solving a major global health problem. GlobalResist is embedded in a consortium of partners from Freie Universitaet Berlin, Charité-Universitaetsmedizin Berlin and Technische Universitaet Berlin and is funded by the Berlin University Alliance. Last day to apply 24 April 2023.

Follow the link for more information: https://www.bcp.fu-berlin.de/en/pharmazie/faecher/klinische_pharmazie/arbeitsgruppe_kloft/offene_stellen/Postdoc/index.html


2023 ISAP Annual Meeting in Copenhagen

The ISAP Annual Meeting is now open for registration.  Please register here before 10 March 2023 for catering purposes.

Attendance is free of charge for ISAP members. Please ensure that you have renewed your membership to be eligible. Click here to renew your membership.


Date: 14th April 2023 (Friday)

Time: 9.30am to 2pm

Venue: Scandic Palace (Rådhuspladsen 57, 1550 Copenhagen V)


9.30am - 10.00am: Registration and breakfast buffet

10.00am - 10.10am: Welcome note

10.10am - 10.50am: Keynote speaker (Professor Oana Ciofu, University of Copenhagen)

10.50am - 12.30pm: Young investigator's talk

12.30pm - 1.15pm: Lunch

1.15pm - 2.00pm: General meeting, award presentation and closing

The meeting will provide opportunities for Young Investigators to present their research. Young Investigators: If you are interested in giving a presentation, please send your abstract to Sue Nang (This email address is being protected from spambots. You need JavaScript enabled to view it.) before 10 March 2023.

 We hope to see you in Copenhagen soon!

EPASG Webinar Friday 16th of December

On Friday 16th of December there will be a webinar by EPASG titled "To TDM or not to TDM: pitfalls and success of MIPD of antibiotics in special populations" 12.00 -13:00 CET.

12:00-12:25: beta lactams and ciprofloxacin by Birgit Koch

12:25-12:45: vancomycin and linezolid by Sonia Luque Pardos

The dial-in info is shared via the newsletter!

Positions available

Postdoc positions available:

The PKPD group at Uppsala University is searching for a devoted postdoc who is enthusiastic about antimicrobial PKPD, and has experience in model-based methods. More info:https://www.uu.se/en/about-uu/join-us/details/?positionId=593734

The Lab of Dr. Zack Bulman in Chicago, IL, USA is looking for a postdoctoral fellow in antimicrobial pharmacology and PK/PD. Kindly refer to this link for the application: https://uic.csod.com/ux/ats/careersite/1/home/requisition/1950?c=uic. Please reach out to Zack (This email address is being protected from spambots. You need JavaScript enabled to view it.) with any questions.

A postdoctoral placement in an industrial environment in Bayer facilities (Frankfurt, Germany) is available starting in 12/2023. 2 mandatory prerequisites to be eligible for the program: a) Australian or New Zealand citizenship, b) PhD thesis in relevant field being submitted latest Oct 2023. Respective applications, consisting of cover letter, curriculum vitae and a scientific dossier covering their synthetic / biochemical topics from Bachelor-, Master-, PhD-work (maximum 5 pages in total), are to be sent to This email address is being protected from spambots. You need JavaScript enabled to view it. by 15th February 2023 in order to allow time for preparation of interviews.


PhD Student (3 yrs.) - University of Hamburg, Germany

The Dept. of Clinical Pharmacy at the University of Hamburg, Germany, is hiring a PhD student. The anticipated starting date is May 2023, but the exact date can be defined individually. The project is embedded in a EU consortium that focuses on optimizing the therapy of ceftazidime/avibactam and fosfomycin against Enterobacterales (JPIAMR - CAVIFOS, https://www.jpiamr.eu/projects/cavifos/). The PhD project will involve pharmacokinetic-pharmacodynamic studies in the hollow-fiber infection model as well as pharmacometric modelling and development of model-informed precision dosing tools to translate the findings into a clinical perspective.

Candidates should have an interest in pharmacokinetics/pharmacodynamics and data sciences. Skills in pharmacometric modelling are helpful, but not mandatory. The application can be submitted here (https://www.uni-hamburg.de/stellenangebote/ausschreibung.html?jobID=b0c1c1cfba91de9237a14bb09ddbbabd928d4695). For further information contact Prof. Sebastian Wicha (This email address is being protected from spambots. You need JavaScript enabled to view it.).

News March 2022

Dear ISAP members!

As the situation in Europe is steadily stabilizing after the pandemic winter, we are pleased to share with you information on two upcoming events around the ECCMID meeting in April 2022:

Prior to ECCMID, on 21-22 April 2022, EPASG is hosting a on-site workshop titled "Optimised dosing of antibiotics - understanding PK/PD, clinical breakpoints, and therapeutic drug monitoring" in Oerias (close to Lisbon), Portugal. ESCMID indicated that the course is filling up quickly. The program can be found here. Register here, if you are interested to join!

ISAP Meeting  
Right after the EPASG course on 22 April 2022, and hence on the evening before ECCMID, we will hold an ISAP Scientific Meeting from 16.30 to approx. 20.00 in the same hotel (Lagoas Park, Oerias) as the EPASG course, in Oerias, Portugal. Registration is now closed.

Location (ca. 20 mins from Lisbon airport/Lisbon city centre by taxi):
Lagoas Park Hotel
Rua Encosta das Lagoas
2740-245 Porto Salvo, Portugal


16.15-16.30 Arrival and Welcome
16.30-17.15 ISAP General Meeting 
17.15-19.00 Young Investigator Session

First name

Last Name




Interaction screening of ceftazidime-avibactam and tigecycline against six clinical and nine isogenic E. coli and K. pneumoniae strains expressing carbapenemases


Van Os

Impact of individual ascitic fluids on bacterial growth and ceftriaxone effect in an in vitro model of spontaneous bacterial peritonitis



Integrated in vitro approach to understand the exposure-effect relationship of fosfomycin against Escherichia coli



A model-based analysis of pharmacokinetic-pharmacodynamic (PK/PD) indices of avibactam against β-lactamase-producing Gram-negative bacteria



PhageGE: An Interactive Web-based R Shiny Application for Bacteriophage Pharmacology



Elucidating the pharmacokinetics/ pharmacodynamics of bacteriophage therapy against Pseudomonas aeruginosa using a mouse bacteraemia model



Semi-mechanistic PKPD modelling of ceftazidime/avibactam and colistin combination against five multidrug resistant Klebsiella pneumoniae isolates



In vitro PK/PD modelling of polymyxin B against resistant strain of A. baumannii in presence of mucin



Model-based TDM of vancomycin: a retrospective comparison with routine TDM-based dosing



Pharmacokinetics and PK/PD of temocillin in non-ICU urinary tract infection patients with various stages of renal insufficiency



Large variability of unbound active fraction of ceftriaxone in contrast to ciprofloxacin in plasma of critically ill patients


Sanz Codina

Relationship between pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill COVID-19 patients with documented Gram-negative superinfections treated with meropenem continuous infusion

19.00-20.00 Reception with light food and beverages

We hope to see you in Portugal, soon!

Best regards

ISAP Council